Logo-aim
Arch Iran Med. 2023;26(3): 138-146.
doi: 10.34172/aim.2023.22
PMID: 37543936
PMCID: PMC10685729
Scopus ID: 85166777197
  Abstract View: 1183
  PDF Download: 612

Original Article

Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study

Hamideh Salimzadeh 1,2* ORCID logo, Catherine Sauvaget 3, Alireza Delavari 1, Anahita Sadeghi 1, Mohammad Amani 1, Sepideh Salimzadeh 1, Azita Karimi 4, Ali Ghanbari Motlagh 5, Eric Lucas 3, Partha Basu 3, Reza Malekzadeh 1

1 Digestive Oncology Research Centre, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Östra, 416 85, Gothenburg, Sweden
3 Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France
4 Deputy of Health, Tehran University of Medical Sciences, Tehran, Iran
5 Cancer Office, Deputy of Health, Ministry of Health, Tehran, Iran
*Corresponding Author: Hamideh Salimzadeh, Email: salimzadeh.h@gmail.com

Abstract

Background: Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative fecal immunochemical test (FIT) among Iranian average-risk adults.

Methods: In this feasibility study, 7039 individuals aged 50–75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHWs performed a qualitative FIT with cut-off level 50 ng Hb/mL buffer and referred those with positive-FIT for colonoscopy to the endoscopy center of Shariati hospital in Tehran. Outcomes included acceptance rate, FIT positivity rate, colonoscopy compliance, detection rates and positive predictive values (PPVs) with 95% confidence interval for CRC and advanced adenomas (AAs).

Results: Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested positive. Among FIT-positive participants, 150 (31.8%) underwent colonoscopy; CRC was detected in 2.0% (n=3) and adenomas in 27.3% (n=41). Detection rate of CRC and AAs per 1000-FIT-screened participants was 0.6 (0.1–1.8) [males: 0.7 (0.01–3.6), females: 0.6 (0.07–2.0)] and 4.2 (2.5–6.4) [males: 5.9 (2.6–11.0), females: 3.4 (1.7–6.0)], respectively. PPVs were 2.0% (0.4–5.7) for CRC and 13.3% (8.3–19.8) for AAs. There was no association between gender and the studied outcomes.

Conclusion: Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healthcare system for adequate colonoscopy services.


Cite this article as: Salimzadeh H, Sauvaget C, Delavari A, Sadeghi A, Amani M, Salimzadeh S, et al. Colorectal cancer screening pilot project in Tehran-Iran, a feasibility study. Arch Iran Med. 2023;26(3):138-146. doi: 10.34172/aim.2023.22
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1184

Your browser does not support the canvas element.


PDF Download: 612

Your browser does not support the canvas element.

Submitted: 26 Feb 2022
Revision: 08 May 2022
Accepted: 23 May 2022
ePublished: 01 Mar 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)